Quipt Home Medical Corp. (QIPT)
USD 2.02
(-8.18%)
USD 2.02
(-8.18%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -2.78 Million USD | -157.53% |
| 2022 | 4.83 Million USD | 178.38% |
| 2021 | -6.17 Million USD | -47.66% |
| 2020 | -4.18 Million CAD | 39.45% |
| 2019 | -6.9 Million CAD | -147.59% |
| 2018 | 14.5 Million CAD | 175.76% |
| 2017 | -19.15 Million CAD | 66.62% |
| 2016 | -57.37 Million CAD | -213.09% |
| 2015 | -18.32 Million CAD | -1207.42% |
| 2014 | -1.4 Million CAD | 43.22% |
| 2013 | -2.46 Million CAD | -350.12% |
| 2012 | -548.4 Thousand CAD | 64.21% |
| 2011 | -1.53 Million CAD | 3.92% |
| 2010 | -1.59 Million CAD | -226.28% |
| 2009 | 1.26 Million CAD | 170.46% |
| 2008 | -1.79 Million CAD | -350.41% |
| 2007 | 715.83 Thousand CAD | 345.27% |
| 2006 | -291.86 Thousand CAD | 58.9% |
| 2005 | -710.12 Thousand CAD | 43.4% |
| 2004 | -1.25 Million CAD | -2920.33% |
| 2003 | -41.54 Thousand CAD | 73.44% |
| 2002 | -156.37 Thousand CAD | 53.53% |
| 2001 | -336.46 Thousand CAD | -39.46% |
| 2000 | -241.26 Thousand CAD | -608.48% |
| 1999 | -34.05 Thousand CAD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -1.35 Million USD | -132.94% |
| 2024 Q3 | -1.7 Million USD | -24.62% |
| 2024 Q1 | -602.19 Thousand USD | 55.81% |
| 2023 FY | -2.78 Million USD | -157.53% |
| 2023 Q3 | -1.03 Million USD | 89.12% |
| 2023 Q4 | -1.32 Million USD | -28.24% |
| 2023 Q2 | -9.5 Million USD | -3023.38% |
| 2023 Q1 | 325 Thousand USD | -81.64% |
| 2022 Q4 | 1.77 Million USD | 985.89% |
| 2022 Q1 | -2.13 Million USD | -42.35% |
| 2022 FY | 4.83 Million USD | 178.38% |
| 2022 Q2 | 5.03 Million USD | 336.32% |
| 2022 Q3 | 163 Thousand USD | -96.76% |
| 2021 FY | -6.17 Million USD | -47.66% |
| 2021 Q2 | -12.49 Million USD | -5554.15% |
| 2021 Q3 | 6.32 Million USD | 150.67% |
| 2021 Q4 | -1.49 Million USD | -123.65% |
| 2021 Q1 | 229 Thousand USD | 110.27% |
| 2020 Q4 | -2.22 Million CAD | 18.4% |
| 2020 FY | -4.18 Million CAD | 39.45% |
| 2020 Q2 | 1.15 Million CAD | 185.93% |
| 2020 Q1 | -1.34 Million CAD | -131.49% |
| 2020 Q3 | -2.73 Million CAD | -336.23% |
| 2019 Q1 | 99.11 Thousand CAD | -92.49% |
| 2019 Q2 | -396.94 Thousand CAD | -500.48% |
| 2019 FY | -6.9 Million CAD | -147.59% |
| 2019 Q3 | -9.55 Million CAD | -2306.22% |
| 2019 Q4 | 4.27 Million CAD | 144.74% |
| 2018 Q3 | -1.09 Million CAD | 62.93% |
| 2018 Q4 | 1.32 Million CAD | 220.34% |
| 2018 FY | 14.5 Million CAD | 175.76% |
| 2018 Q1 | 17.98 Million CAD | 230.74% |
| 2018 Q2 | -2.95 Million CAD | -116.46% |
| 2017 Q4 | -13.75 Million CAD | -498.02% |
| 2017 Q1 | -3.01 Million CAD | 92.64% |
| 2017 Q3 | -2.29 Million CAD | -15434.92% |
| 2017 FY | -19.15 Million CAD | 66.62% |
| 2017 Q2 | 14.99 Thousand CAD | 100.5% |
| 2016 Q3 | -5.78 Million CAD | 42.45% |
| 2016 Q1 | -527.41 Thousand CAD | 16.72% |
| 2016 FY | -57.37 Million CAD | -213.09% |
| 2016 Q4 | -40.92 Million CAD | -607.28% |
| 2016 Q2 | -10.05 Million CAD | -1806.5% |
| 2015 FY | -18.32 Million CAD | -1207.42% |
| 2015 Q2 | -1.77 Million CAD | 27.18% |
| 2015 Q4 | -633.29 Thousand CAD | 95.08% |
| 2015 Q3 | -12.87 Million CAD | -625.82% |
| 2015 Q1 | -2.43 Million CAD | 15.93% |
| 2014 Q4 | -2.89 Million CAD | -376.41% |
| 2014 FY | -1.4 Million CAD | 43.22% |
| 2014 Q3 | 1.04 Million CAD | 108.12% |
| 2014 Q1 | 131.76 Thousand CAD | 104.91% |
| 2014 Q2 | 503.56 Thousand CAD | 282.18% |
| 2013 Q2 | 76.64 Thousand CAD | -20.95% |
| 2013 Q4 | -2.68 Million CAD | -5037.6% |
| 2013 FY | -2.46 Million CAD | -350.12% |
| 2013 Q3 | 54.29 Thousand CAD | -29.15% |
| 2013 Q1 | 96.95 Thousand CAD | 218.46% |
| 2012 Q2 | -193.71 Thousand CAD | -19.59% |
| 2012 Q4 | -81.84 Thousand CAD | 28.16% |
| 2012 Q3 | -113.93 Thousand CAD | 41.18% |
| 2012 FY | -548.4 Thousand CAD | 64.21% |
| 2012 Q1 | -161.98 Thousand CAD | 45.59% |
| 2011 Q3 | -396.11 Thousand CAD | 7.18% |
| 2011 FY | -1.53 Million CAD | 3.92% |
| 2011 Q1 | -397.31 Thousand CAD | 41.56% |
| 2011 Q2 | -426.76 Thousand CAD | -7.41% |
| 2011 Q4 | -297.71 Thousand CAD | 24.84% |
| 2010 Q4 | -679.83 Thousand CAD | 25.43% |
| 2010 Q1 | 56.31 Thousand CAD | 221.51% |
| 2010 Q2 | -80.91 Thousand CAD | -243.68% |
| 2010 FY | -1.59 Million CAD | -226.28% |
| 2010 Q3 | -911.68 Thousand CAD | -1026.7% |
| 2009 FY | 1.26 Million CAD | 170.46% |
| 2009 Q4 | -46.34 Thousand CAD | -106.91% |
| 2009 Q3 | 671.03 Thousand CAD | 1018.34% |
| 2009 Q2 | -73.07 Thousand CAD | -106.03% |
| 2009 Q1 | 1.21 Million CAD | 302.24% |
| 2008 Q3 | -1.48 Million CAD | -999.72% |
| 2008 Q2 | -135.3 Thousand CAD | -8.58% |
| 2008 Q1 | -124.61 Thousand CAD | -143.68% |
| 2008 FY | -1.79 Million CAD | -350.41% |
| 2008 Q4 | -598.69 Thousand CAD | 59.77% |
| 2007 FY | 715.83 Thousand CAD | 345.27% |
| 2007 Q4 | -51.14 Thousand CAD | 69.38% |
| 2007 Q3 | -166.99 Thousand CAD | -12.4% |
| 2007 Q2 | -148.56 Thousand CAD | -119.35% |
| 2007 Q1 | 767.61 Thousand CAD | 1852.36% |
| 2006 FY | -291.86 Thousand CAD | 58.9% |
| 2006 Q2 | 60.14 Thousand CAD | 125.42% |
| 2006 Q1 | -236.63 Thousand CAD | -250.54% |
| 2006 Q3 | -48.93 Thousand CAD | -181.37% |
| 2006 Q4 | -43.8 Thousand CAD | 10.49% |
| 2005 FY | -710.12 Thousand CAD | 43.4% |
| 2005 Q1 | -202.45 Thousand CAD | -4.24% |
| 2005 Q2 | 45.33 Thousand CAD | 122.39% |
| 2005 Q3 | -351.77 Thousand CAD | -875.97% |
| 2005 Q4 | -67.5 Thousand CAD | 80.81% |
| 2004 Q2 | -191.92 Thousand CAD | -838.76% |
| 2004 Q3 | -1 Million CAD | -424.16% |
| 2004 Q4 | -194.22 Thousand CAD | 80.69% |
| 2004 FY | -1.25 Million CAD | -2920.33% |
| 2004 Q1 | 25.97 Thousand CAD | 132.5% |
| 2003 Q1 | -30.54 Thousand CAD | -92.52% |
| 2003 FY | -41.54 Thousand CAD | 73.44% |
| 2003 Q4 | -79.94 Thousand CAD | -3701.06% |
| 2003 Q3 | -2103.23 CAD | -120.06% |
| 2003 Q2 | 10.48 Thousand CAD | 134.33% |
| 2002 Q1 | -35.21 Thousand CAD | -1.49% |
| 2002 FY | -156.37 Thousand CAD | 53.53% |
| 2002 Q3 | -107.97 Thousand CAD | -612.47% |
| 2002 Q4 | -15.86 Thousand CAD | 85.3% |
| 2002 Q2 | 21.07 Thousand CAD | 159.83% |
| 2001 Q4 | -34.7 Thousand CAD | 0.0% |
| 2001 FY | -336.46 Thousand CAD | -39.46% |
| 2000 FY | -241.26 Thousand CAD | -608.48% |
| 1999 FY | -34.05 Thousand CAD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | -61.61 Million USD | 95.482% |
| BrainsWay Ltd. | -4.19 Million USD | 33.667% |
| Cerus Corporation | -37.48 Million USD | 92.574% |
| Envoy Medical, Inc. | -29.9 Million USD | 90.691% |
| electroCore, Inc. | -18.83 Million USD | 85.218% |
| Helius Medical Technologies, Inc. | -8.85 Million USD | 68.542% |
| IceCure Medical Ltd | -14.65 Million USD | 80.999% |
| Inogen, Inc. | -102.44 Million USD | 97.283% |
| OrthoPediatrics Corp. | -20.97 Million USD | 86.726% |
| Lucid Diagnostics Inc. | -52.66 Million USD | 94.714% |
| Monogram Orthopaedics, Inc. | -13.74 Million USD | 79.746% |
| MaxCyte, Inc. | -37.92 Million USD | 92.659% |
| NeuroOne Medical Technologies Corporation | -11.85 Million USD | 76.525% |
| Nexalin Technology, Inc. | -4.64 Million USD | 40.112% |
| Orthofix Medical Inc. | -151.39 Million USD | 98.161% |
| PAVmed Inc | -64.17 Million USD | 95.662% |
| Rapid Micro Biosystems, Inc. | -52.46 Million USD | 94.694% |
| RxSight, Inc. | -48.6 Million USD | 94.273% |
| Sight Sciences, Inc. | -55.54 Million USD | 94.988% |
| SI-BONE, Inc. | -43.33 Million USD | 93.576% |
| TELA Bio, Inc. | -46.66 Million USD | 94.034% |
| Treace Medical Concepts, Inc. | -49.52 Million USD | 94.379% |
| Vivos Therapeutics, Inc. | -13.58 Million USD | 79.504% |
| Acutus Medical, Inc. | -81.66 Million USD | 96.591% |
| Talis Biomedical Corporation | -62 Million USD | 95.51% |
| Spectral AI, Inc. | -20.85 Million USD | 86.65% |
| Nano-X Imaging Ltd. | -60.77 Million USD | 95.419% |
| CVRx, Inc. | -41.19 Million USD | 93.243% |
| DIH Holding US, Inc. Warrants | 640.19 Thousand USD | 534.867% |
| PetVivo Holdings, Inc. | -10.95 Million USD | 74.588% |
| Bioventus Inc. | -156.23 Million USD | 98.218% |
| Venus Concept Inc. | -37.25 Million USD | 92.526% |
| TriSalus Life Sciences, Inc. | -59.03 Million USD | 95.284% |
| LivaNova PLC | 17.54 Million USD | 115.867% |
| 908 Devices Inc. | -36.39 Million USD | 92.351% |
| Alphatec Holdings, Inc. | -186.63 Million USD | 98.508% |
| Nemaura Medical Inc. | -14.14 Million USD | 80.316% |
| NeuroPace, Inc. | -32.95 Million USD | 91.552% |
| LENSAR, Inc. | -14.38 Million USD | 80.644% |
| Apyx Medical Corporation | -18.71 Million USD | 85.123% |
| Cutera, Inc. | -162.83 Million USD | 98.29% |
| STRATA Skin Sciences, Inc. | -10.83 Million USD | 74.294% |
| BioSig Technologies, Inc. | -29.04 Million USD | 90.414% |
| Anika Therapeutics, Inc. | -82.66 Million USD | 96.632% |
| ClearPoint Neuro, Inc. | -22.08 Million USD | 87.396% |
| Integra LifeSciences Holdings Corporation | 67.74 Million USD | 104.11% |
| Axonics, Inc. | -6.08 Million USD | 54.271% |
| Outset Medical, Inc. | -172.79 Million USD | 98.389% |
| IRIDEX Corporation | -9.57 Million USD | 70.909% |
| PROCEPT BioRobotics Corporation | -105.89 Million USD | 97.371% |
| IRadimed Corporation | 17.19 Million USD | 116.193% |
| Tivic Health Systems, Inc. | -8.24 Million USD | 66.23% |
| INVO Bioscience, Inc. | -8.03 Million USD | 65.35% |
| Telesis Bio, Inc. | -47.72 Million USD | 94.166% |
| Viemed Healthcare, Inc. | 10.24 Million USD | 127.18% |
| Varex Imaging Corporation | -47.7 Million USD | 94.164% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | 75.332% |
| Pulmonx Corporation | -60.84 Million USD | 95.424% |
| Dynatronics Corporation | -2.69 Million USD | -3.198% |
| Modular Medical, Inc. | -17.47 Million USD | 84.064% |
| ReShape Lifesciences Inc. | -11.38 Million USD | 75.551% |
| Semler Scientific, Inc. | 20.58 Million USD | 113.526% |
| InMode Ltd. | 197.91 Million USD | 101.407% |
| Bruker Corporation | 427.2 Million USD | 100.652% |
| Cytosorbents Corporation | -28.5 Million USD | 90.234% |
| DexCom, Inc. | 541.5 Million USD | 100.514% |
| Align Technology, Inc. | 445.05 Million USD | 100.626% |
| Viveve Medical, Inc. | -22.02 Million USD | 87.361% |
| ZimVie Inc. | -393.28 Million USD | 99.292% |
| Movano Inc. | -29.28 Million USD | 90.493% |
| Cytek Biosciences, Inc. | -12.14 Million USD | 77.083% |
| Nexalin Technology, Inc. | -4.64 Million USD | 40.112% |
| DIH Holdings US, Inc. Class A Common Stock | 640.19 Thousand USD | 534.867% |
| Tandem Diabetes Care, Inc. | -222.61 Million USD | 98.749% |
| Profound Medical Corp. | -28.56 Million USD | 90.255% |
| Insulet Corporation | 206.3 Million USD | 101.349% |
| enVVeno Medical Corporation | -23.51 Million USD | 88.161% |
| Surmodics, Inc. | -11.54 Million USD | 75.879% |
| iCAD, Inc. | -4.84 Million USD | 42.562% |
| Nuwellis, Inc. | -20.2 Million USD | 86.224% |
| Biotricity, Inc. | -14.09 Million USD | 80.247% |
| iRhythm Technologies, Inc. | -123.4 Million USD | 97.744% |
| Aethlon Medical, Inc. | -12.2 Million USD | 77.196% |
| InspireMD, Inc. | -19.91 Million USD | 86.021% |
| PAVmed Inc. | -64.17 Million USD | 95.662% |
| BIOLASE, Inc. | -20.63 Million USD | 86.506% |
| Beyond Air, Inc. | -60.24 Million USD | 95.379% |
| FONAR Corporation | 10.56 Million USD | 126.345% |
| AxoGen, Inc. | -21.71 Million USD | 87.18% |
| Vivani Medical, Inc. | -25.65 Million USD | 89.147% |
| Tactile Systems Technology, Inc. | 28.51 Million USD | 109.763% |
| Inari Medical, Inc. | -1.63 Million USD | -70.171% |
| UFP Technologies, Inc. | 44.92 Million USD | 106.197% |
| QT Imaging Holdings, Inc. | -5.13 Million USD | 45.756% |
| Heart Test Laboratories, Inc. | -6.6 Million USD | 57.851% |
| Tenon Medical, Inc. | -15.58 Million USD | 82.132% |
| Autonomix Medical, Inc. Common Stock | -15.42 Million USD | 81.953% |
| Co-Diagnostics, Inc. | -35.33 Million USD | 92.121% |
| AdaptHealth Corp. | -678.89 Million USD | 99.59% |
| Sintx Technologies, Inc. | -8.25 Million USD | 66.291% |
| NanoVibronix, Inc. | -3.71 Million USD | 24.98% |
| Quanterix Corporation | -32.33 Million USD | 91.39% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | 75.332% |
| Sensus Healthcare, Inc. | 485 Thousand USD | 674.021% |
| Pacific Biosciences of California, Inc. | -306.73 Million USD | 99.092% |
| TransMedics Group, Inc. | -25.02 Million USD | 88.876% |
| ReWalk Robotics Ltd. | -22.13 Million USD | 87.421% |
| NeuroMetrix, Inc. | -6.52 Million USD | 57.363% |
| Hyperfine, Inc. | -44.23 Million USD | 93.707% |
| Establishment Labs Holdings Inc. | -78.5 Million USD | 96.454% |
| Biomerica, Inc. | -5.97 Million USD | 53.429% |
| Bone Biologics Corporation | -8.94 Million USD | 68.889% |
| AVITA Medical, Inc. | -39.16 Million USD | 92.892% |
| Bluejay Diagnostics, Inc. | -9.95 Million USD | 72.031% |
| Silk Road Medical, Inc | -55.74 Million USD | 95.006% |